10 Best Rising Penny Stocks to Buy According to Analysts
In this article, we will look at the 10 Best Rising Penny Stocks to Buy According to Analysts.
Posts Tagged ‘NASDAQ:RGLS’
10 Best Short-Term Stocks To Buy Right Now
This article will look into the 10 best short-term stocks with a buying opportunity for investors.
10 Cheapest Stocks Insiders Are Buying Recently
In this article, we will take a detailed look at the 10 cheapest stocks insiders are buying recently.
Regulus Therapeutics Inc. (NASDAQ:RGLS) Q3 2022 Earnings Call Transcript
Regulus Therapeutics Inc. (NASDAQ:RGLS) Q3 2022 Earnings Call Transcript November 10, 2022 Regulus Therapeutics Inc. misses on earnings expectations.
13 Best Biotech Penny Stocks To Buy Now
In this article, we will be taking a look at the 13 best biotech penny stocks to buy now.
Insider Buying at Regulus Therapeutics Inc (RGLS) Sends Stock Soaring
What: Regulus Therapeutics Inc (NASDAQ:RGLS) shares have jumped $0.30 per share, or 24%, to $1.55 in after hours on Thursday.
How Regulus Therapeutics Inc (RGLS) Stacks Up Against Its Peers
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable...
Why Are These Stocks Deep in Red Today?
Although the three major indexes have each opened 1% higher, a number of stocks have lost ground in Tuesday intraday trading.
What’s Going On With These 5 Trending Stocks?
U.S stocks are trading down ever so slightly on this fine Friday afternoon.
Is Regulus Therapeutics Inc (RGLS) Going to Burn These Hedge Funds?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track more than 700 prominent money managers...
Trellus Management’s Top Biotech Stock Picks For Q4
Trellus Management is a New York-based long/short equity hedge fund founded by Adam Usdan in 1994.
RA Capital Is Expecting A Breakthrough Cardiovascular Drug From This Biotech
The biotechnology industry is up by more than 50% over the last year, but these towering returns don't come without great risk and volatility.
Regulus Therapeutics Inc (RGLS), Trevena Inc (TRVN), Juno Therapeutics Inc (JUNO): RA Capital’s Top New Biotech Picks
Peter Kolchinsky’s RA Capital Management filed its latest 13F with the Securities and Exchange Commission in February, and we’ve gone through the data to highlight three of...
Hedge Fund Resource Center
